Connect with:
Saturday / April 20. 2024
HomeAgribusinessBest Agrolife acquires Sudarshan Farm Chemicals India Pvt Ltd

Best Agrolife acquires Sudarshan Farm Chemicals India Pvt Ltd

The acquisition, finalised through a 100 per cent stake purchase with cash consideration, amounts to an estimated enterprise value of Rs 139 Crores.

Best Agrolife Ltd (BAL), a prominent player in the Indian agrochemicals industry, has made a significant stride with the acquisition of Sudarshan Farm Chemicals India Pvt Ltd (SFCL). This acquisition marks a milestone in BAL’s journey, as it not only expands its market presence but also strengthens its R&D capabilities and product portfolio.

The acquisition, finalised through a 100 per cent stake purchase with cash consideration, amounts to an estimated enterprise value of Rs 139 Crores. After accounting for Net Working Capital and other Liabilities, the cash outflow for BAL is expected to be around Rupees 9.5 Crore. This strategic move is aimed at leveraging SFCL’s expertise in R&D and brand management to enhance BAL’s market position and drive growth.

SFCL, a subsidiary of Sudarshan Chemical Industries, boasts a rich legacy of 40 years in the agrochemicals sector. Known for its commitment to quality and innovation, SFCL has earned the trust of farmers across the country. The company’s focus on developing cost-effective manufacturing routes for off-patent molecules has been a key driver of its success.

One of the key assets acquired by BAL through this deal is SFCL’s impressive IP portfolio, which includes 10 patents (applied). This portfolio, combined with SFCL’s R&D capabilities, will provide BAL with a competitive edge in developing new and innovative products for the market.

The acquisition also grants BAL access to SFCL’s popular brands, including “Sutathion,” “Suphos,” “Suchlor,” and “Sumidon.” These brands, known for their quality and effectiveness, will complement BAL’s existing product lineup and help expand its presence in the central and southern regions of India.

No comments

leave a comment